Common retatrutide side effects from the Phase 2 trial The largest published study on retatrutide the Phase 2 trial by Jastreboff et al., published in the NEJM in 2023 enrolled 338 adults with obesity
Funding None
For patients who prefer online access, telehealth alternatives offer similar GLP-1 medications starting at $297/month with free consultations and home delivery
Our mobile team of IV-certified licensed medical professionals bring the MED-IVee experience to you.For an additional fee of $300 our licensed professional will visit your home or business and provide your custom IV drip or booster shot
Wellness Wednesdays A weekly reminder to your inbox every Wednesday on how to prioritize your self-care, delicious recipes, exclusive deals, and the behind-the-scenes deep dive into everything that can help enhance you and your health journey
Ex-4 alone, or in combination with the ghrelin antagonist, in the NAc shell but not core, reduced alcohol intake in a time-dependent manner (Abtahi et al., 2018)